loading

Forte Biosciences Inc Borsa (FBRX) Ultime notizie

pulisher
Feb 06, 2025

Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - MarketBeat

Feb 06, 2025
pulisher
Feb 03, 2025

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings -February 03, 2025 at 09:03 am EST - Marketscreener.com

Feb 03, 2025
pulisher
Feb 01, 2025

(FBRX) Proactive Strategies - Stock Traders Daily

Feb 01, 2025
pulisher
Jan 25, 2025

TD Cowen initiates Forte Biosciences stock with Buy rating - MSN

Jan 25, 2025
pulisher
Jan 25, 2025

Forte Biosciences expands equity incentive plan By Investing.com - Investing.com Australia

Jan 25, 2025
pulisher
Jan 24, 2025

Forte Biosciences expands equity incentive plan - MSN

Jan 24, 2025
pulisher
Jan 23, 2025

Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

Forte Biosciences (NASDAQ:FBRX) Coverage Initiated by Analysts at TD Cowen - Defense World

Jan 22, 2025
pulisher
Jan 21, 2025

TD Cowen initiates Forte Biosciences stock with Buy rating By Investing.com - Investing.com Australia

Jan 21, 2025
pulisher
Jan 21, 2025

Atopic Dermatitis Drugs Market Trends Analysis Report - GlobeNewswire

Jan 21, 2025
pulisher
Jan 11, 2025

(FBRX) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Jan 11, 2025
pulisher
Jan 09, 2025

Forte Biosciences Target of Unusually High Options Trading (NASDAQ:FBRX) - Defense World

Jan 09, 2025
pulisher
Jan 06, 2025

Forte Biosciences (FBRX) Is a Great Choice for 'Trend' Investors, Here's Why - MSN

Jan 06, 2025
pulisher
Dec 31, 2024

(FBRX) Technical Data - Stock Traders Daily

Dec 31, 2024
pulisher
Dec 26, 2024

Investors Purchase Large Volume of Put Options on Evelo Biosciences (NASDAQ:EVLO) - Defense World

Dec 26, 2024
pulisher
Dec 26, 2024

Investors Buy High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World

Dec 26, 2024
pulisher
Dec 21, 2024

(FBRX) Long Term Investment Analysis - Stock Traders Daily

Dec 21, 2024
pulisher
Dec 16, 2024

Why Forte Biosciences (FBRX) Stock Is Trading Lower - Benzinga

Dec 16, 2024
pulisher
Dec 13, 2024

CBD Life Sciences Inc. (OTCMKTS:CBDL) Short Interest Up 8,233.3% in November - Defense World

Dec 13, 2024
pulisher
Dec 13, 2024

Traders Buy Large Volume of Call Options on Quantum-Si (NASDAQ:QSI) - Defense World

Dec 13, 2024
pulisher
Dec 12, 2024

Invea Therapeutics Strengthens Leadership with Appointment of Dr. Stephen Doberstein, Veteran Biotech Executive, to Its Board of Directors - The Manila Times

Dec 12, 2024
pulisher
Dec 10, 2024

Trading (FBRX) With Integrated Risk Controls - Stock Traders Daily

Dec 10, 2024
pulisher
Dec 05, 2024

FBRX Stock Soars to 52-Week High, Reaching $24.46 By Investing.com - Investing.com Nigeria

Dec 05, 2024
pulisher
Dec 05, 2024

Forte Biosciences’ $53 Million Equity Financing - Global Legal Chronicle

Dec 05, 2024
pulisher
Dec 02, 2024

Biopharma Takes on Deadly Brain Cancer After Decades of Failure - BioSpace

Dec 02, 2024
pulisher
Nov 30, 2024

(FBRX) Trading Report - Stock Traders Daily

Nov 30, 2024
pulisher
Nov 29, 2024

Here's Why Momentum in Forte Biosciences (FBRX) Should Keep going - MSN

Nov 29, 2024
pulisher
Nov 27, 2024

FBRX Stock Soars to 52-Week High, Reaching $21.47 - Investing.com India

Nov 27, 2024
pulisher
Nov 27, 2024

FBRX Stock Soars to 52-Week High, Reaching $21.47 By Investing.com - Investing.com UK

Nov 27, 2024
pulisher
Nov 25, 2024

Forte Biosciences Sets R&D Day to Showcase FB102 Autoimmune Treatment Pipeline | FBRX Stock News - StockTitan

Nov 25, 2024
pulisher
Nov 22, 2024

Forte Biosciences CFO acquires $124,997 in company stock By Investing.com - Investing.com Canada

Nov 22, 2024
pulisher
Nov 22, 2024

Forte Biosciences CFO acquires $124,997 in company stock - Investing.com

Nov 22, 2024
pulisher
Nov 21, 2024

More than $50M raised by publicly traded drug developer - The Business Journals

Nov 21, 2024
pulisher
Nov 21, 2024

Dallas' Forte Biosciences Announces $53M Private Placement From Leading Healthcare Investors - dallasinnovates.com

Nov 21, 2024
pulisher
Nov 21, 2024

Forte Biosciences Stock More Than Doubles On Oversubscribed $53M Private Placement: Retail Goes Wild - MSN

Nov 21, 2024
pulisher
Nov 21, 2024

EDIT Stock Drops Amid Market Volatility in Biotech Sector - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

Cidara’s $100M PIPE; Pyxis Oncology’s stock falls on Phase 1 data - Endpoints News

Nov 21, 2024
pulisher
Nov 21, 2024

Stock market today: Pyxis Oncology plunges by 47.25% while Perspective Therapeutics declines by 46.68% in early trading - Business Upturn

Nov 21, 2024
pulisher
Nov 21, 2024

Forte Biosciences secures $53 million in funding By Investing.com - Investing.com Canada

Nov 21, 2024
pulisher
Nov 21, 2024

Lexicon Pharmaceuticals (LXRX) Stock Plummets Amidst Market Acti - GuruFocus.com

Nov 21, 2024
pulisher
Nov 20, 2024

Artelo Biosciences (ARTL) Stock Surges Amid Strong Buy Ratings - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

5 Stocks Retail Investors Are Most Bullish On At Mid-Day - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Forte Biosciences Secures $53M for FB102 Advancements - TipRanks

Nov 20, 2024
pulisher
Nov 20, 2024

Terns Pharmaceuticals (TERN) Stock Drops Over 5% Amidst Mixed In - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

Forte Biosciences Shares Are Soaring Today: What's Going On? - Benzinga

Nov 20, 2024
pulisher
Nov 20, 2024

Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results - Benzinga

Nov 20, 2024
pulisher
Nov 20, 2024

Forte Biosciences secures $53 million in funding - Investing.com India

Nov 20, 2024
pulisher
Nov 20, 2024

Forte Biosciences More Than Doubles on $53M Private Placement - MarketWatch

Nov 20, 2024
$79.57
price down icon 1.36%
$20.24
price down icon 0.29%
$352.49
price down icon 0.35%
$5.08
price up icon 1.59%
biotechnology ONC
$225.37
price down icon 1.84%
$118.70
price down icon 1.15%
Capitalizzazione:     |  Volume (24 ore):